Cargando…
Japan's COVID‐19 treatment strategy: An examination of approved oral medications
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651642/ https://www.ncbi.nlm.nih.gov/pubmed/37691254 http://dx.doi.org/10.1111/cts.13628 |
| _version_ | 1785136035641950208 |
|---|---|
| author | Higuchi, Yuka Kaneda, Yudai Tanimoto, Tetsuya |
| author_facet | Higuchi, Yuka Kaneda, Yudai Tanimoto, Tetsuya |
| author_sort | Higuchi, Yuka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10651642 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106516422023-09-18 Japan's COVID‐19 treatment strategy: An examination of approved oral medications Higuchi, Yuka Kaneda, Yudai Tanimoto, Tetsuya Clin Transl Sci Perspective John Wiley and Sons Inc. 2023-09-18 /pmc/articles/PMC10651642/ /pubmed/37691254 http://dx.doi.org/10.1111/cts.13628 Text en © 2023 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspective Higuchi, Yuka Kaneda, Yudai Tanimoto, Tetsuya Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title | Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title_full | Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title_fullStr | Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title_full_unstemmed | Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title_short | Japan's COVID‐19 treatment strategy: An examination of approved oral medications |
| title_sort | japan's covid‐19 treatment strategy: an examination of approved oral medications |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651642/ https://www.ncbi.nlm.nih.gov/pubmed/37691254 http://dx.doi.org/10.1111/cts.13628 |
| work_keys_str_mv | AT higuchiyuka japanscovid19treatmentstrategyanexaminationofapprovedoralmedications AT kanedayudai japanscovid19treatmentstrategyanexaminationofapprovedoralmedications AT tanimototetsuya japanscovid19treatmentstrategyanexaminationofapprovedoralmedications |